NEU 1.05% $15.11 neuren pharmaceuticals limited

ACAD presentation, page-6

  1. 13,012 Posts.
    lightbulb Created with Sketch. 778
    hottod: "...I do think Acadia could lodge a bid, if they really wanted to. But, as I already said in a post early last month, I doubt they would be willing to pay more than ~ US$500m."

    hottod/others: "hottod" - many THANKS for your kind explanations about the FINANCIAL POWER that Acadia does in fact HAVE! Therefore, for me it is basically a question IF ACADIA wants to
    A) become a WORLDWIDE pharma-enterprise OR
    B) remain just "only" a successful US pharma company

    IF A) they should launch a take-over bid for the WHOLE of the NEU pipeline but with a really substantial OFFER (i.e. not a 'measly' US$ 500m, i.e. one that would/will be really "to good to refuse" (somewhere in the territory between A$ 14 - A$ 18 should 'do the trick...' - just my guess).
    IF B) NEU will have to discuss very carefully with potential (hopefully BIG PHARMA) partners for ROW, so that they are not 'just working' on behalf of Acadia instead of mainly their own interests going forward.

    All the aforementioned as usual JIMHO, of course. Comments welcome as always!

    wasa

 
watchlist Created with Sketch. Add NEU (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.